| Douglas Roberts, MD | |
|
4923 Cloister Dr, Rockville, MD 20852-3363 | |
| (301) 530-8104 | |
| Not Available |
| Full Name | Douglas Roberts |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 4923 Cloister Dr, Rockville, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033305537 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | D0037730 (Maryland) | Primary |
| 208000000X | Pediatrics | D0037730 (Maryland) | Secondary |
| 208U00000X | Clinical Pharmacology | D0037730 (Maryland) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Douglas Roberts, MD 4923 Cloister Dr, Rockville, MD 20852-3363 Ph: (301) 530-8104 | Douglas Roberts, MD 4923 Cloister Dr, Rockville, MD 20852-3363 Ph: (301) 530-8104 |
News Archive
The novel coronavirus (2019-nCoV or Wuhan coronavirus) is spreading like wildfire across the globe and health officials are racing to contain the virus. Experts in the United Kingdom warn that the country is facing a major coronavirus outbreak in the coming weeks as the number of confirmed cases rises to four, as more than 25 countries have reported increasing case toll.
Following the announcement on July 13 by Québec's Minister of Health and Social Services, Dr. Yves Bolduc, that assisted reproduction treatments (ART) will be covered by the public health system of Québec as of August 5, 2010, many comments have been made about how this new policy will stress the public health system, and neonatology units in particular.
Oral disease, primarily dental caries, is the most common pediatric disease and can lead to physical and psychological disabilities as well as significant morbidity in adulthood.
Today, an advisory committee of the US Food and Drug Administration (FDA) recommended approval of FTY720 (fingolimod) for the treatment of patients with relapsing multiple sclerosis, the most common form of the disease. The FDA has the option of seeking the advice of one of its advisory committees as it reviews and decides whether to approve a new treatment. The committee voted unanimously that FTY720 demonstrated substantial efficacy in treating relapsing remitting MS and that safety of the proposed 0.5 mg dose justified approval.
› Verified 6 days ago
Dr. Sheila Gay Levin, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 14955 Shady Grove Rd, Suite 150, Rockville, MD 20850 Phone: 301-340-3252 Fax: 301-340-1423 | |
Dr. Shubir Sofat, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 10110 Molecular Dr Ste 200, Rockville, MD 20850 Phone: 301-610-4000 Fax: 301-610-4007 | |
Dr. Kajal Dasgupta, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2101 E Jefferson St, Kaiser Permanente Medicare Enrollment, Rockville, MD 20852 Phone: 301-816-2424 | |
Joseph M Haggerty, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9707 Medical Center Dr, Suite 300, Rockville, MD 20850 Phone: 301-424-6231 Fax: 301-294-4648 | |
Isabelle A Hertig, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 11125 Rockville Pike, Suite 208, Rockville, MD 20852 Phone: 301-881-5858 Fax: 301-260-2838 | |
Dr. Wellington Sun, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1401 Rockville Pike, Suite 300n, Rockville, MD 20852 Phone: 301-827-3070 Fax: 301-827-3532 | |
Dr. Wei Fan, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2401 Research Blvd Ste 370, Rockville, MD 20850 Phone: 240-690-4114 Fax: 240-654-3915 |